Piebaldism is an autosomal dominant genetic disorder of pigmentation characterized by congenital patches of white skin and hair that lack melanocytes. Piebaldism results from mutations of the KIT proto-oncogene, which encodes the ceJlular receptor transmembrane tyrosine kinase for mast/stem cell growth factor. Here we describe two novel KIT mutations associated with human piebaldism. These amino acid P iebaldism is a rare autosomal dominant genetic disorder of melanocyte development characterized by white patches of skin and hair that completely lack pigment, located principally on the scalp, forehead, ventral chest and abdomen, and extremities [1-3J. Melanocytes are absent from the regions of leukoderma [4,SJ, and piebaldism is thought to result from defective melanocyte proliferation or migration from the neural crest during development. In contrast to vitiligo, with which it is often confused, piebaldism is both congenital and non-progressive. Because of its distinctive ph~noty'pe, p~ebald ism has been known since at least anCient Greek times 16]. Piebaldism was one of the first genetic disorders for which a pedigree was presented [7] , and sever~1 families have been reported that trace inheritance of the disorder over hundreds of years (reviewed in [2]). Etymologically, "pie" apparently refers to the variegated blackand-white plumage pattern characteristic of the magpie, and "bald" derives from the Greek pha/iDs, "having a white spot." In mice, a disorder similar to human piebaldism, "dominant white spotting" (W), characterized by defects of pigmentation, hematopoiesis, and germ-cell development (reviewed in [8, 9] ), results from deletions or point mutations of the KIT proto-oncogene [10] [11] [12] [13] [14] [15] [16] . KIT, originally identified as an oncogene in the HZ4-fclille sarcoma virus [17J, encodes the cell surface transmembrane receytor protein tyrosine kinase for the mast/stem cell growth factor [18-21J. The KIT receptor polypeptide consists of a penta-repetitive extracellular ligand-binding domain, a short transmembrane domain, and a bipartite intracellular tyrosine kinase domain [22) . On binding of growth factor ligand to the extracellular domain, the KIT receptor monomer undergoes dimerization within the cell membrane, activating the kinase and initiating the signal-transduction process (reviewed in [23, 24] The human KIT gene consists of 21 exons spanning more than 3~ kbp of DNA [25] at chromosome segment 4q11-q12 [22, 26] . Th~ observation of interstitial deletions of chromosome segment 4ql~ in some patients with piebaldism [27 -30J initially suggested that human piebaldism, like mouse dominant white spotting, migh\ result from defects of the KIT gene. This hypothesis was supporteq by the demonstration of complete deletion of the KIT gene in twq patients with piebaldism [31, 32] . We [33-35J and others [36] hav~ recently described a variety of point mutations of the KIT gene i~ patients with piebaldism. Here we report two novel missense muta, tions in the tyrosine kinase domain of the KIT gene in two addi\ tional families with piebaldism. The human KIT gene mutatio~ closely parallel those of mouse and would be expected to dominant\ negatively disrupt function of the KIT receptor, resulting ulth mately in the aberrant embryologic distribution of melanocytes that is characteristic of piebaldism.
substitutions, located in the most highly conserved sectiol1\ of the KIT kinase domain, would be expected to dominant\ negatively inhibit KIT-dependent signal transduction, reI suiting in aberrant melanocyte proliferation or migratio~ during embryologic development. ] Invest Dermatol1 01 :22 "\ 25, 1993 The human KIT gene consists of 21 exons spanning more than 3~ kbp of DNA [25] at chromosome segment 4q11-q12 [22, 26] . Th~ observation of interstitial deletions of chromosome segment 4ql~ in some patients with piebaldism [27 -30J initially suggested that human piebaldism, like mouse dominant white spotting, migh\ result from defects of the KIT gene. This hypothesis was supporteq by the demonstration of complete deletion of the KIT gene in twq patients with piebaldism [31, 32] . We [33-35J and others [36] hav~ recently described a variety of point mutations of the KIT gene i~ patients with piebaldism. Here we report two novel missense muta, tions in the tyrosine kinase domain of the KIT gene in two addi\ tional families with piebaldism. The human KIT gene mutatio~ closely parallel those of mouse and would be expected to dominant\ negatively disrupt function of the KIT receptor, resulting ulth mately in the aberrant embryologic distribution of melanocytes that is characteristic of piebaldism.
MATEIUALS AND METHODS
Description of Pro bands Family 1 is a large kindred from Cap~ Verde Island (Africa) in which piebaldism can be traced for at leas\ four generations. Proband 1 exhibited a large white forelock an~ extensive leukoderma of the forehead and abdomen, with numerous. hyperpigmented macules and cafe-au-Iait spots interspersed among and within the regions of hypopigmentation. A complete blood count was within normal limits. The proband's only child, a daugh, ter, also exhibited white forelock and extensive leukoderma of tbr abdomen, arms, and legs, with numerous interspersed hyperpig, mented macules.
Family 2, in which piebaldism can be traced over three genera, tions, has previously been described in detail in the literature [37] : proband 2 is individual III -5 of that kindred. The piebald phenotyp~ in this family is also relatively severe, including white forelocks and extensive leukoderma of the forehead, chin, ventral trunk, and ex, trernities. Numerous hyperpigmented macules and cafe-au-lait spOil are interspersed within and among the regions of hypopigmentation.
Polymerase Chain Reaction Amplification and Analysis of the Human KIT Gene The 21 exons of the human KIT gene and their flanking sequences [25] DNA of probands 1 and 2 and an unrelated, normally J:?igmented person by 35 cycles of the polymerase chain reaction [38) using oligonucleotide primers exactly as previously described [34, 35) . The amplified fragments were then screened for single-base changes by simultaneous single-strand conformation polymorphism (SSCP)jheteroduplex analyses, also exactly as described [35) . Exon fragments that yielded clearly abnormal or suspicious patterns were independently reamplified in duplicate from genomic DNA and cloned in M13mp18, and at least six independent clones of each w ere subjected to DNA sequence analyses [39) .
Segregation Analysis A 277 -bp fragment containing KIT exon 17 plus portions of the adjacent intervening sequences was polymerase chain reaction amplified from DNA of the proband of family 2, her similarly affected daughter and sister, and an unrelated normally pigmented person. The amplification products were subjected to SSCP jheteroduplex analysis, as described above, and scored for the aberrant or the normal exon 17 pattern. abnormal heteroduplex pattern. The SSCP pattern, although reproducibly quite faint, was also abnormal. Analyses of the remainder of the KIT exons of the proband appeared normal (data not shown) .
RESULTS

Proband of Family 1 is Heterozygous for a Missense
The exon 17 segment was independently reamplified from genomic DNA of proband 1 and cloned in M13mp18 . As shown in Fig 2A, DNA sequence analyses demonstrated that she is heterozygous for a single-base substitution within codon 791, within the intracellular tyrosine kinase domain. This substirution, AGA -+ GGA, results in the substitution of glycine for the normal arginine at this site. Fig 1, exon 17 of the proband exhibited abnormalities of both the SSCP and heteroduplex patterns. Analyses of the remainder of the KIT exons of the proband appeared normal (data not shown).
Proband of
The exon 17 segment was independently reamplified from genomic DNA of proband 1 and cloned in M13mp18. As shown in Fig 2B, DNA sequence analyses demonstrated that she is heterozygous for a single-base substitution within codon 812, within the intracellular tyrosine kinase domain. This substirution, GGT -+ GTT, results in the substitution of valine for the normal glycine at this site.
SSCP jheteroduplex analysis of KIT exon 17 fragments polymerase chain reaction amplified from DNA of the proband's similarly affected daughter and sister likewise demonstrated the same aberrant patterns as the proband (Fig 1) . Thus, the codon 812 mutation appears to co-segregate with the piebald phenotype in this family.
DISCUSSION
We used the approach of polymerase chain reaction amplification, rapid screening by combined SSCP jheteroduplex analysis, and subsequent DNA sequence analysis to quickly and efficiently identify two novel mutations of the KIT gene in patients with piebaldism. Both are missense substitutions located within the intracellular tyrosine kinase domai n of the 976-amino acid KIT polypeptide.
Missense substitutions in the KIT tyrosine kinase domain inhibit function of the KIT receptor in a so-called dominant-negative manner. Receptor homodimers composed of two mutant KIT polypeptides containing substitutions in the tyrosine kinase domain lack kinase activity. However, receptor heterodimers formed between a normal and a mutant KIT monomer also lack kinase activity [40] [41] [42] [43] . Thus, KIT-dependent signal transduction is reduced by approximately 75% in persons heterozygous for KIT kinase domain substirutions, accounting for the autosomal dominant mode of inheritance associated with piebaldism.
The codon 791 mutation of proband 1 is almost certainly pathologic. It is not a common polymorphism. We have not observed it in similar analyses of 37 other unrelated people. Furthermore, codon 791 is located in the center of region Vlb of the highly conserved kinase domain, one of the two most highly conserved portions of the kinase domain. In fact, the amino acid sequence of codons 790-792, His-Arg-Asp, is absolutely invariant among all known protein tyrosine kinases (reviewed in [44) ) , and the substitution of neutral glycine for basic arginine at the central position of this triplet would almost certainly be deleterious. Of interest, this human KIT gene mutation is only two amino acids away from the mouse W 42 mutation, at codon 790 [14) (note that the codon numbering of the human and mOllse KIT polypeptides are not precisely the same), an additional indication that this region is particularly important for function of the IUT receptor kinase.
Similarly, the codon 812 mutation of proband 2 is also almost certainly pathologic. It is also not a common polymorphism, not occurring among 37 other unrelated persons. This mutation co-segregates with the piebald phenotype in first-degree relatives of the proband. Codon 812 is located in the center of region VII of the In fac t, all of the seven human KIT missense substitutions thus far observed in patients with piebaldism ( (33 ,34,36] ; this report; unpublished data) closely parallel the fiv e known KIT missense substitutions o f W mu ta nt mice with "dominant white spotting." As noted above, th e codon 791 and 812 substitutions described her~ correspond cl osely to the mouse W42 and W f substitutions, respec, tively. W e previously reported human KIT substitutions at codon\ 584 [34] and 664 [33] , w hi ch , respectively, correspond closely t (\ th e mouse W 37 [1 2,13] 
